Correlations between DW‐MRI and 18F‐FDG PET/CT parameters in head and neck squamous cell carcinoma following definitive chemo‐radiotherapy

Posttreatment diffusion–weighted magnetic resonance imaging (DW‐MRI) and 18F‐fluorodeoxygluocose (18F‐FDG) positron emission tomography (PET) with computed tomography (PET/CT) have potential prognostic value following chemo‐radiotherapy (CRT) for head and neck squamous cell carcinoma (HNSCC). Correlations between these PET/CT (standardized uptake value or SUV) and DW‐MRI (apparent diffusion coefficient or ADC) parameters have only been previously explored in the pretreatment setting.

• Publication year

  2021

• Venue

  Cancer Reports

• Publication date

  2021-05-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/cnr2.1360PMID 33960739PMCID 8388179
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Correlations between DW‐MRI and 18F‐FDG PET/CT parameters in head and neck squamous cell carcinoma following definitive chemo‐radiotherapy

  2021cited by this paper
• Post-treatment FDG PET-CT in head and neck carcinoma: comparative analysis of 4 qualitative interpretative criteria in a large patient cohort

  2020cited by this paper
• The utility of multiparametric MRI to characterize hypoxic tumor subvolumes in comparison to FMISO PET/CT. Consequences for diagnosis and chemoradiation treatment planning in head and neck cancer.

  2020cited by this paper
• Does multiparametric imaging with 18F-FDG-PET/MRI capture spatial variation in immunohistochemical cancer biomarkers in head and neck squamous cell carcinoma?

  2020cited by this paper
• Utility of Likert scale (Deauville criteria) in assessment of Chemoradiotherapy response of primary oropharyngeal squamous cell Cancer site.

  2019cited by this paper
• Prognostic value of FDG PET/CT during radiotherapy in head and neck cancer patients

  2018cited by this paper
• Associations Between [18F]FDG-PET and Complex Histopathological Parameters Including Tumor Cell Count and Expression of KI 67, EGFR, VEGF, HIF-1α, and p53 in Head and Neck Squamous Cell Carcinoma

  2018cited by this paper
• Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods

  2018cited by this paper
• FDG-PET/CT for treatment response assessment in head and neck squamous cell carcinoma: a systematic review and meta-analysis of diagnostic performance

  2018cited by this paper
• Preoperative diagnostic of parotid gland neoplasms: fine-needle aspiration cytology or core needle biopsy?

  2018cited by this paper
• Maximum Standardized Uptake Value (SUVmax) of Primary Tumor Predicts Occult Neck Metastasis in Oral Cancer

  2018cited by this paper
• The prediction of the treatment response of cervical nodes using intravoxel incoherent motion diffusion-weighted imaging.

  2017cited by this paper
• Predictive value of pre-treatment apparent diffusion coefficient (ADC) in radio-chemiotherapy treated head and neck squamous cell carcinoma

  2017cited by this paper
• The role of changes in maximum standardized uptake value of FDG PET-CT for post-treatment surveillance in patients with head and neck squamous cell carcinoma treated with chemoradiotherapy: preliminary findings.

  2017cited by this paper
• Associations between 18F-FDG-PET, DWI, and DCE Parameters in Patients with Head and Neck Squamous Cell Carcinoma Depend on Tumor Grading

  2017cited by this paper
• Radiologic Differences between Human Papillomavirus-Related and Human Papillomavirus-Unrelated Oropharyngeal Carcinoma on Diffusion-Weighted Imaging

  2017cited by this paper
• Local recurrence of squamous cell carcinoma of the head and neck after radio(chemo)therapy: Diagnostic performance of FDG-PET/MRI with diffusion-weighted sequences

  2017cited by this paper
• Predictive and prognostic value of PET/CT imaging post-chemoradiotherapy and clinical decision-making consequences in locally advanced head & neck squamous cell carcinoma: a retrospective study

  2016cited by this paper
• Combining standardized uptake value of FDG-PET and apparent diffusion coefficient of DW-MRI improves risk stratification in head and neck squamous cell carcinoma

  2016cited by this paper
• Simultaneous (18)F-FDG-PET/MRI: Associations between diffusion, glucose metabolism and histopathological parameters in patients with head and neck squamous cell carcinoma.

  2016cited by this paper
• Dynamic contrast-enhanced MRI, diffusion-weighted MRI and 18F-FDG PET/CT for the prediction of survival in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation

  2016cited by this paper
• The Predictive Value of Early Assessment After 1 Cycle of Induction Chemotherapy with 18F-FDG PET/CT and Diffusion-Weighted MRI for Response to Radical Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma

  2016cited by this paper
• PET-CT surveillance versus neck dissection in advanced head and neck cancer

  2016cited by this paper
• PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer.

  2016cited by this paper
• Overview of the predictive value of quantitative 18 FDG PET in head and neck cancer treated with chemoradiotherapy.

  2016cited by this paper
• 18F-FDG uptake on PET correlates with biological potential in early oral squamous cell carcinoma

  2015cited by this paper
• Primary Tumor Standardized Uptake Value Predicts Survival in Head and Neck Squamous Cell Carcinoma

  2015cited by this paper
• Diffusion-Weighted MRI in the Assessment of Early Treatment Response in Patients with Squamous-Cell Carcinoma of the Head and Neck: Comparison with Morphological and PET/CT Findings

  2015cited by this paper
• Reliability of post-chemoradiotherapy F-18-FDG PET/CT for prediction of locoregional failure in human papillomavirus-associated oropharyngeal cancer.

  2014cited by this paper
• Immunologic and metabolic characteristics of HPV-negative and HPV-positive head and neck squamous cell carcinomas are strikingly different

  2014cited by this paper
• Fractional Change in Apparent Diffusion Coefficient as an Imaging Biomarker for Predicting Treatment Response in Head and Neck Cancer Treated with Chemoradiotherapy

  2014cited by this paper
• Diffusion-weighted EPI- and HASTE-MRI and 18F-FDG-PET-CT early during chemoradiotherapy in advanced head and neck cancer.

  2014cited by this paper
• Correlation of Standardized Uptake Value and Apparent Diffusion Coefficient in Integrated Whole-Body PET/MRI of Primary and Recurrent Cervical Cancer

  2014cited by this paper
• Head and Neck PET/CT: Therapy Response Interpretation Criteria (Hopkins Criteria)—Interreader Reliability, Accuracy, and Survival Outcomes

  2014cited by this paper
• Functional imaging of head and neck squamous cell carcinoma with diffusion-weighted MRI and FDG PET/CT: quantitative analysis of ADC and SUV

  2013cited by this paper
• Pretreatment diffusion-weighted and dynamic contrast-enhanced MRI for prediction of local treatment response in squamous cell carcinomas of the head and neck.

  2013cited by this paper
• Can 18F-FDG PET/CT Reliably Assess Response to Primary Treatment of Head and Neck Cancer?

  2013cited by this paper
• Head and neck squamous cell carcinoma: diagnostic performance of diffusion-weighted MR imaging for the prediction of treatment response.

  2013cited by this paper
• FDG PET/CT and Diffusion-Weighted Imaging of Head and Neck Squamous Cell Carcinoma: Comparison of Prognostic Significance Between Primary Tumor Standardized Uptake Value and Apparent Diffusion Coefficient

  2012cited by this paper
• The role of positron emission tomography/CT imaging in head and neck cancer patients after radical chemoradiotherapy.

  2012cited by this paper
• Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma.

  2012cited by this paper
• Retrospective review of positron emission tomography with contrast-enhanced computed tomography in the posttreatment setting in human papillomavirus-associated oropharyngeal carcinoma.

  2012cited by this paper
• Functional imaging in head and neck squamous cell carcinoma: correlation of PET/CT and diffusion-weighted imaging at 3 Tesla

  2011cited by this paper
• Apparent Diffusion Coefficient Calculated with Relatively High b-Values Correlates with Local Failure of Head and Neck Squamous Cell Carcinoma Treated with Radiotherapy

  2011cited by this paper
• Results of a prospective study of positron emission tomography–directed management of residual nodal abnormalities in node‐positive head and neck cancer after definitive radiotherapy with or without systemic therapy

  2011cited by this paper
• Correlation of 18F-FDG Uptake with Apparent Diffusion Coefficient Ratio Measured on Standard and High b Value Diffusion MRI in Head and Neck Cancer

  2011cited by this paper
• Diffusion weighted imaging in predicting progression free survival in patients with squamous cell carcinomas of the head and neck treated with induction chemotherapy.

  2011cited by this paper
• Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response

  2010cited by this paper
• Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer.

  2009cited by this paper
• Accuracy of positron emission tomography in the evaluation of patients treated with chemoradiotherapy for mucosal head and neck cancer

  2009cited by this paper
• The diagnostic and prognostic utility of positron emission tomography/computed tomography‐based follow‐up after radiotherapy for head and neck cancer

  2009cited by this paper
• Pretreatment FDG‐PET standardized uptake value as a prognostic factor for outcome in head and neck cancer

  2009cited by this paper
• Diffusion-Weighted Magnetic Resonance Imaging for Predicting and Detecting Early Response to Chemoradiation Therapy of Squamous Cell Carcinomas of the Head and Neck

  2009cited by this paper
• HPV-Related Nonkeratinizing Squamous Cell Carcinoma of the Oropharynx: Utility of Microscopic Features in Predicting Patient Outcome

  2009cited by this paper
• Clinical Utility of 18F-FDG PET/CT in Assessing the Neck After Concurrent Chemoradiotherapy for Locoregional Advanced Head and Neck Cancer

  2008cited by this paper
• Head and neck squamous cell carcinoma: usefulness of diffusion-weighted MR imaging in the prediction of a neoadjuvant therapeutic effect

  2008cited by this paper
• 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography as guidance for primary treatment in patients with advanced-stage resectable squamous cell carcinoma of the larynx and hypopharynx.

  2007cited by this paper
• Salvage Surgery with Free Flap Reconstruction: Factors Affecting Outcome After Treatment of Recurrent Head and Neck Squamous Carcinoma

  2007cited by this paper
• Prognostic factors in salvage surgery for recurrent oral and oropharyngeal cancer

  2006cited by this paper
• FDG-PET prediction of head and neck squamous cell cancer outcomes.

  2004cited by this paper
• Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT?

  2004cited by this paper
• Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma.

  2002cited by this paper
• FDG–PET. A possible prognostic factor in head and neck cancer

  2002cited by this paper
• Laryngeal or hypopharyngeal squamous cell carcinoma: can follow-up CT after definitive radiation therapy be used to detect local failure earlier than clinical examination alone?

  2000cited by this paper
• Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer.

  1997cited by this paper

• Adjuvant metronomic tegafur-uracil is associated with poorer outcomes and unfavorable histopathologic progression in oral squamous cell carcinomas

  2025cites this paper
• MRI for Differentiation between HPV-Positive and HPV-Negative Oropharyngeal Squamous Cell Carcinoma: A Systematic Review

  2024cites this paper
• The Prognostic Significance of Tumor SUVmax Value in Pre- and Post-Chemoradiotherapy 18F-FDG PET/CT Imaging in Patients with Localized and Advanced Head and Neck Squamous Cell Carcinoma.

  2024cites this paper
• Management of Recurrent HPV-Positive Oropharyngeal Squamous Cell Carcinoma: a Contemporary Review

  2023cites this paper
• Diffusion-weighted imaging and apparent diffusion coefficient mapping of head and neck lymph node metastasis: a systematic review

  2022influential citation
• Imaging Diagnosis of Primary Liver Cancer Using Magnetic Resonance Dilated Weighted Imaging and the Treatment Effect of Sorafenib

  2022cites this paper
• Correlations between DW‐MRI and 18F‐FDG PET/CT parameters in head and neck squamous cell carcinoma following definitive chemo‐radiotherapy

  2021cites this paper